Clinical trials
Triple Negative Breast Neoplasms trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 8 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Active, not recruiting | 14 |
| Terminated | 10 |
| Recruiting | 6 |
| Unknown status | 2 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 10 |
| Merck Sharp & Dohme LLC | 8 |
| AbbVie | 7 |
| Hoffmann-La Roche | 5 |
| AstraZeneca | 4 |
| Gilead Sciences | 3 |
| National Taiwan University Hospital | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Alterome Therapeutics, Inc. | 1 |
| Arcus Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 52 |
| Carcinoma, Non-Small-Cell Lung | 17 |
| Breast Neoplasms | 13 |
| Neoplasms | 10 |
| Ovarian Neoplasms | 9 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Stomach Neoplasms | 9 |
| Melanoma | 8 |
| Carcinoma, Hepatocellular | 6 |
| Colorectal Neoplasms | 6 |
Trials
Showing 76 to 52 of 52. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.